Molecular and Epidemiologic Characterization of a Pathogenic Human Bocavirus
致病性人博卡病毒的分子和流行病学特征
基本信息
- 批准号:7315319
- 负责人:
- 金额:$ 20.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:Age DistributionAntibodiesBackBaculovirusesBiological AssayBiologyBovine Papillomavirus-1CapsidCapsid ProteinsCell Culture SystemCell LineCellsChildChildhoodClinicalCohort StudiesCommunicable DiseasesCultured CellsDNA biosynthesisDetectionDiagnosticDisease AssociationEmbryoEnzymesEpidemiologic StudiesEpidemiologyEpithelial CellsFamilyFibroblastsGenomeHumanHuman Cell LineImmunoglobulin GImmunoglobulin MIn VitroInfantInfectionInsectaLengthLinkLungMolecularMolecular GeneticsMolecular VirologyMonoclonal AntibodiesMusNon-Small-Cell Lung CarcinomaOryctolagus cuniculusParvovirusPatientsPolymerase Chain ReactionPopulationPrincipal InvestigatorProteinsRateReagentRecombinantsResearchResearch DesignRespiratory Tract DiseasesRetrospective StudiesRoleSamplingSerologicalSerumSimian virus 40SymptomsTestingTransfectionViralViral GenomeVirionVirusVirus-like particlebasebovine parvovirusgene cloningmemberpathogenpolyclonal antibodypolypeptideprogramsprospectiverespiratorytoolvectorvirology
项目摘要
DESCRIPTION (provided by applicant): A newly discovered human bocavirus, HBoV - a member of the parvovirus family - appears to be a significant respiratory pathogen prevalent in children. This application proposes a collaborative effort to further characterize this virus by a molecular virology group with extensive parvovirus research expertise and a pediatric infectious disease group with a proven track record of discovery in pediatric virology and epidemiology. We have identified several pediatric samples that contain the virus, as detected by diagnostic PCR, and have cloned the gene for the predicted major viral capsid protein from these samples, into a baculovirus vector. Infection of insect cells with this baculovirus results in expression of the bocaviral polypeptide and its efficient assembly into virus-like particles (VLPs). VLPs will be produced in the quantities necessary to produce HboV capsid-specific polyclonal and monoclonal antibodies, and to develop an ELISA for the detection of anti-capsid IgG and IgM antibodies. A combination of PCR and ELISA will be used, in both prospective and retrospective studies, to explore the distribution and disease associations of HBoV in the human population, particularly within our large pediatric study group. We will attempt to grow the virus and study its biology in cell culture. For this we will produce antibodies able to detect putative viral non-structural gene products expressed in HBoV infected cell, and establish an infected-cell culture system for the closely- related bovine parvovirus (BPV-1), in order to validate these reagents. We will inoculate several potentially appropriate human cell lines, such as embryonic lung fibroblasts, non-small cell lung cancer, SV40- transformed lung epithelial cells and stepwise immortalized and transformed airway epithelial cells. These will be examined for their ability to support single- and multiple-round infections with HoBV, using the serological reagents generated as above. Once we have identified a cell line capable of expanding HBoV in culture, we will purify viral genomes from virions grown in such cells, construct a full-length clone of the virus by in vitro DNA replication, and test its infectivity following transfection back into competent host cells in vitro. These studies are designed to develop new tools for the detection and isolation of the newly-discovered human bocavirus (HboV), and to identify antibodies to this virus in human serum. These tools will be used to establish the basic epidemiology of HboV and to explore its role in respiratory illness among infants.
描述(由申请人提供):一种新发现的人类博卡病毒,HBoV(细小病毒家族的成员)似乎是儿童中流行的重要呼吸道病原体。该申请提议由具有广泛细小病毒研究专业知识的分子病毒学小组和在儿科病毒学和流行病学方面拥有良好发现记录的儿科传染病小组合作,进一步表征该病毒。我们已经通过诊断性 PCR 检测到了几个含有该病毒的儿科样本,并将这些样本中预测的主要病毒衣壳蛋白的基因克隆到杆状病毒载体中。用这种杆状病毒感染昆虫细胞会导致博卡病毒多肽表达并有效组装成病毒样颗粒(VLP)。 VLP 的生产量将用于生产 HboV 衣壳特异性多克隆和单克隆抗体,并开发用于检测抗衣壳 IgG 和 IgM 抗体的 ELISA。将在前瞻性和回顾性研究中结合使用 PCR 和 ELISA,以探索 HBoV 在人群中的分布和疾病关联,特别是在我们的大型儿科研究组中。我们将尝试在细胞培养中培养病毒并研究其生物学。为此,我们将生产能够检测HBoV感染细胞中表达的假定病毒非结构基因产物的抗体,并建立密切相关的牛细小病毒(BPV-1)的感染细胞培养系统,以验证这些试剂。我们将接种几种可能合适的人类细胞系,例如胚胎肺成纤维细胞、非小细胞肺癌、SV40转化的肺上皮细胞以及逐步永生化和转化的气道上皮细胞。将使用上述生成的血清学试剂检查它们支持 HoBV 单轮和多轮感染的能力。一旦我们确定了能够在培养物中扩增 HBoV 的细胞系,我们将从在此类细胞中生长的病毒体中纯化病毒基因组,通过体外 DNA 复制构建病毒的全长克隆,并在体外转染回感受态宿主细胞后测试其感染性。 这些研究旨在开发新工具来检测和分离新发现的人类博卡病毒(HboV),并鉴定人血清中针对该病毒的抗体。这些工具将用于建立 HboV 的基本流行病学并探讨其在婴儿呼吸道疾病中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter J. Tattersall其他文献
Peter J. Tattersall的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter J. Tattersall', 18)}}的其他基金
Host genes controlling rodent protoparvovirus tissue and species tropism
控制啮齿动物原细小病毒组织和种向性的宿主基因
- 批准号:
10193407 - 财政年份:2021
- 资助金额:
$ 20.63万 - 项目类别:
Host genes controlling rodent protoparvovirus tissue and species tropism
控制啮齿动物原细小病毒组织和种向性的宿主基因
- 批准号:
10385761 - 财政年份:2021
- 资助金额:
$ 20.63万 - 项目类别:
Armed oncolytic parvoviral vectors for modulating the tumor microenvironment
用于调节肿瘤微环境的武装溶瘤细小病毒载体
- 批准号:
9795232 - 财政年份:2019
- 资助金额:
$ 20.63万 - 项目类别:
Molecular Genetics of Parvoviral DNA Replication
细小病毒 DNA 复制的分子遗传学
- 批准号:
8070912 - 财政年份:2010
- 资助金额:
$ 20.63万 - 项目类别:
Molecular Genetics of Parvoviral DNA Replication
细小病毒 DNA 复制的分子遗传学
- 批准号:
7846562 - 财政年份:2009
- 资助金额:
$ 20.63万 - 项目类别:
Molecular and Epidemiologic Characterization of a Pathogenic Human Bocavirus
致病性人博卡病毒的分子和流行病学特征
- 批准号:
7457986 - 财政年份:2007
- 资助金额:
$ 20.63万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 20.63万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 20.63万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 20.63万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 20.63万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:














{{item.name}}会员




